Atherosclerosis
Volume 208, Issue 1 , Pages 43-49 , January 2010

Cyclooxygenase-2 derived thromboxane A2 and reactive oxygen species mediate flow-induced constrictions of venules in hyperhomocysteinemia

  • Anita Racz

      Affiliations

    • Department of Pathophysiology, Semmelweis University, Budapest, Hungary
    • ,
  • Zoltan Veresh

      Affiliations

    • Department of Pathophysiology, Semmelweis University, Budapest, Hungary
    • Department of Physiology, New York Medical College, Valhalla, NY, USA
    • ,
  • Gabor Lotz

      Affiliations

    • 2nd Department of Pathology, Semmelweis University, Budapest, Hungary
    • ,
  • Zsolt Bagi

      Affiliations

    • Department of Physiology, New York Medical College, Valhalla, NY, USA
    • ,
  • Akos Koller

      Affiliations

    • Department of Pathophysiology, Semmelweis University, Budapest, Hungary
    • Department of Physiology, New York Medical College, Valhalla, NY, USA
    • Department of Pathophysiology and Gerontology, University of Pécs, Pécs, Hungary
    • Corresponding Author InformationCorresponding author at: Department of Physiology, New York Medical College, Valhalla, NY 10595, USA. Tel.: +1 914 594 4085; fax: +1 914 594 4018.

Received 14 January 2009 ,Revised 2 June 2009 ,Accepted 8 June 2009.

References 

  1. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165–176
  2. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762
  3. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–236
  4. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(Suppl. 1):S56–S64
  5. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128
  6. Ungvari Z, Csiszar A, Bagi Z, Koller A. Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol. 2002;161:145–153
  7. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb. 1993;13:1327–1333
  8. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906–1914
  9. Cantu C, Alonso E, Jara A, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke. 2004;35:1790–1794
  10. Kanbay M, Karakus S, Yilmaz U. Portal vein thrombosis due to hyperhomocysteinemia caused by vitamin B-12 deficiency. Dig Dis Sci. 2005;50:2362–2363
  11. Starakis I, Mougiou A, Leonidou L, Siagris D, Karatza C. Splenic thrombosis in three patients with moderate hyperhomocysteinemia, low folate and the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene. Thromb Haemost. 2005;94:1333–1334
  12. Blondel J, Glacet-Bernard A, Bayani N, et al. Retinal vein occlusion and hyperhomocysteinemia. J Fr Ophtalmol. 2003;26:249–253
  13. Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollar L, Koller A. Simultaneously increased TxA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 2000;20:1203–1208
  14. Kuo L, Arko F, Chilian WM, Davis MJ. Coronary venular responses to flow and pressure. Circ Res. 1993;72:607–615
  15. Koller A, Dornyei G, Kaley G. Flow-induced responses in skeletal muscle venules: modulation by nitric oxide and prostaglandins. Am J Physiol. 1998;275:H831–836
  16. Racz A, Toth E, Veresh Z, Toth J, Koller A. Increased role of prostaglandin H-2/thromboxane A(2) (PGH(2)/TXA(2)) in mediation of flow dependent responses of gracilis muscle venules in hyperhomocysteinemia (HHcy). FASEB J. 2007;21:A846–a847
  17. Bagi Z, Ungvari Z, Koller A. Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite. Arterioscler Thromb Vasc Biol. 2002;22:28–33
  18. Ungvari Z, Csiszar A, Edwards JG, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2003;23:418–424
  19. Davi G, Di Minno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124–1128
  20. Huang A, Sun D, Koller A, Kaley G. Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol. 1998;275:R1571–1577
  21. Huang A, Sun D, Kaley G, Koller A. Estrogen preserves regulation of shear stress by nitric oxide in arterioles of female hypertensive rats. Hypertension. 1998;31:309–314
  22. Cattaneo M. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost. 2006;32:716–723
  23. Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease.. Circulation. 1998;97:437–443
  24. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217–246
  25. Hirsch S, Ronco AM, Pinardi G, et al. Lack of effect of diet-induced hypomethylation on endothelium-dependent relaxation in rats. Clin Nutr. 2008;27:895–899
  26. Blobaum AL, Marnett LJ. Structural and functional basis of cyclooxygenase inhibition. J Med Chem. 2007;50:1425–1441
  27. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2003;285:H1404–H1410
  28. Kanani PM, Sinkey CA, Browning RL, et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 1999;100:1161–1168
  29. Misra HP. Generation of superoxide free radical during the autooxidation of thiols. J Biol Chem. 1974;249:2151–2155
  30. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab. 2005;6:27–36
  31. Goetschkes T, Toth J, Debreczeni B, Tamas R, Koller A. Hydrogen peroxide elicits prostaglandins-mediated constriction of isolated skeletal muscle venules. FASEB J. 2006;20:A1400
  32. Armstead WM, Mirro R, Busija DW, Leffler CW. Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol. 1988;255:H401–H403
  33. Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res. 1986;59:612–619
  34. Outinen PA, Sood SK, Liaw PC, et al. Characterization of the stress-inducing effects of homocysteine. Biochem J. 1998;332(Pt 1):213–221
  35. Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett. 2000;486:159–162
  36. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986;77:1370–1376
  37. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996;98:24–29
  38. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J. 1997;11:1157–1168
  39. Constans J, Blann AD, Resplandy F, et al. Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. Atherosclerosis. 1999;147:411–413
  40. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731–741
  41. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet. 1991;338:1550–1554

PII: S0021-9150(09)00487-0

doi: 10.1016/j.atherosclerosis.2009.06.014

Atherosclerosis
Volume 208, Issue 1 , Pages 43-49 , January 2010

Article Tools

* Image Usage & Resolution